Marinus Pharmaceuticals Inc
NASDAQ:MRNS
Marinus Pharmaceuticals Inc
Revenue
Marinus Pharmaceuticals Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Marinus Pharmaceuticals Inc
NASDAQ:MRNS
|
Revenue
$31m
|
CAGR 3-Years
162%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Revenue
$85.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Revenue
$45.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
11%
|
|
Pfizer Inc
NYSE:PFE
|
Revenue
$55.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
1%
|
|
Merck & Co Inc
NYSE:MRK
|
Revenue
$61.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
Eli Lilly and Co
NYSE:LLY
|
Revenue
$35.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
See Also
What is Marinus Pharmaceuticals Inc's Revenue?
Revenue
31m
USD
Based on the financial report for Dec 31, 2023, Marinus Pharmaceuticals Inc's Revenue amounts to 31m USD.
What is Marinus Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 3Y
162%
Over the last year, the Revenue growth was 22%. The average annual Revenue growth rates for Marinus Pharmaceuticals Inc have been 162% over the past three years .